CLSD: Clearside Biomedical, Inc. Stock

by  •  • Comments Off on CLSD: Clearside Biomedical, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 78.48
Enterprise Value ($M) 113.78
Book Value ($M) -34.79
Book Value / Share -0.47
Price / Book -2.26
NCAV ($M) -38.84
NCAV / Share -0.52
Price / NCAV -2.02

Profitability (mra)
Return on Invested Capital (ROIC) -2.10
Return on Assets (ROA) -0.93
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 4.49
Current Ratio 4.49

Balance Sheet (mrq) ($M)
Current Assets 25.11
Assets 29.16
Liabilities 63.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2023-11-01 13G/A Whitmore Bradford T 10.10 4.11

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 140,555 427,187 32.90
2024-11-14 32,038 136,228 23.52
2024-11-13 69,259 267,268 25.91
2024-11-12 53,862 237,072 22.72
2024-11-11 98,979 326,577 30.31

(click for more detail)

Similar Companies
CARM – Carisma Therapeutics, Inc. CGTX – Cognition Therapeutics, Inc.
CHRS – Coherus BioSciences, Inc. CLYM – Climb Bio, Inc.
CMRX – Chimerix, Inc.


Financial data and stock pages provided by
Fintel.io